Drug use indicators at St Mary's Clinic
Ball, D.E.; Maidza, J.; Rusike, T.; Sharief, K.; Taderera, T.; Tangawarima, T.
Central African Journal of Medicine 46(2): 54-55
2000
ISSN/ISBN: 0008-9176 PMID: 14674211 Document Number: 521162
Document emailed within 1 workday
Related Documents
Stevens, P. 1983: Nursing care study. Mary, Mary, quite contrary Nursing Times 79(22): 50-53Pickens, A. 1978: Mary Carter agreements and disclosure by drug manufacturers Texas Medicine 74(10): 27-28
McCauley, H.L.; Silverman, J.G.; Decker, M.R.; Agénor, M.; Borrero, S.; Tancredi, D.J.; Zelazny, S.; Miller, E. 2015: Sexual and Reproductive Health Indicators and Intimate Partner Violence Victimization Among Female Family Planning Clinic Patients who have Sex with Women and Men Journal of Women's Health 24(8): 621-628
Miller, K.; Muyindike, W.; Matthews, L.T.; Kanyesigye, M.; Siedner, M.J. 2017: Program Implementation of Option B+ at a President's Emergency Plan for AIDS Relief-Supported HIV Clinic Improves Clinical Indicators But Not Retention in Care in Mbarara, Uganda AIDS patient care and STDs 31(8): 335-341
Riaz, H.; Godman, B.; Bashir, S.; Hussain, S.; Mahmood, S.; Waseem, D.; Malik, F.; Raza, S.A. 2016: Evaluation of Drug use Indicators for Non-Communicable Diseases in Pakistan Acta Poloniae Pharmaceutica 73(3): 787-794
Habrat, E.; Walecka, W. 1988: Psychological indicators of the effectiveness of drug therapy of endogenous depression (review of the literature) Psychiatria Polska 22(4): 333-337
Ohmori, S.; Shiraki, K.; Inoue, H.; Okano, H.; Yamanaka, T.; Deguchi, M.; Sakai, T.; Takase, K.; Nakano, T.; Tameda, Y. 2003: Clinical characteristics and prognostic indicators of drug-induced fulminant hepatic failure Hepato-Gastroenterology 50(53): 1531-1534
Hong, S.Y.; Jonas, A.; Dumeni, E.; Badi, A.; Pereko, D.; Blom, A.; Muthiani, V.S.; Shiningavamwe, A.N.; Mukamba, J.; Andemichael, G.; Barbara, R.; Bennett, D.E.; Jordan, M.R. 2010: Population-based monitoring of HIV drug resistance in Namibia with early warning indicators Journal of Acquired Immune Deficiency Syndromes 55(4): 27-31
Dzangare, J.; Gonese, E.; Mugurungi, O.; Shamu, T.; Apollo, T.; Bennett, D.E.; Kelley, K.F.; Jordan, M.R.; Chakanyuka, C.; Cham, F.; Banda, R.M. 2012: Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(Suppl 4): S313-S316
Sigaloff, K.C.E.; Hamers, R.L.; Menke, J.; Labib, M.; Siwale, M.; Ive, P.; Botes, M.E.; Kityo, C.; Mandaliya, K.; Wellington, M.; Osibogun, A.; Geskus, R.B.; Stevens, W.S.; van Vugt, M.èl.; Rinke de Wit, T.F. 2012: Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(Suppl 4): S294-S299
Childs-Clarke, A.; Cottrell, D. 1984: An 11-year follow-up of drug clinic attenders Nursing Times 80(50): 52-53
Waller, P.C.; Ramsay, L.E. 1988: Arthritis and drug therapy in the hypertension clinic Biomedicine and PharmacoTherapy 42(3): 207-211
Lankosz, J.; Weselucha, P. 1974: Doxepin, a new antidepressive drug for internal clinic Przeglad Lekarski 31(5): 573-577
Dalton, W.S. 1993: Drug resistance modulation in the laboratory and the clinic Seminars in Oncology 20(1): 64-69
Al-Niemat, S.I.; Bloukh, D.T.; Al-Harasis, M.D.; Al-Fanek, A.F.; Salah, R.K. 2008: Drug use evaluation of antibiotics prescribed in a Jordanian hospital outpatient and emergency clinics using WHO prescribing indicators Saudi Medical Journal 29(5): 743-748
Ma, Y.; Zhang, F.; Li, H.; Wu, H.; Zhang, J.; Ding, Y.; Zhao, D.; Fang, H.; Zhou, S.; Liu, Z.; Zhang, L.; Osborne, C.; Seguy, N.; Zhao, Y. 2012: Monitoring HIV drug resistance using early warning indicators in China: results from a pilot survey conducted in 2008 Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(Suppl 4): S300-S302
Lertpiriyasuwat, C.; Teeraratkul, A.; Suchonwanich, Y.; Chatharojwong, N.; Phokasawad, K.; Yuktanon, P.; Pattarapayoon, N.; Bhakeecheep, S.; Bertagnolio, S.; Roels, T.H.; Thanprasertsuk, S. 2017: Monitoring HIV Drug Resistance: Early Warning Indicators to Assess Performance of Thailand's Antiretroviral Treatment Program Journal of the Medical Association of Thailand 100(9): 944-952
Daoni, E.; Kitur, U.; Parunga, A.; Ndenzako, F.; Lloyd, A.; Yu, D. 2012: Experience in piloting HIV drug resistance early warning indicators to improve the antiretroviral program in Papua New Guinea Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54 Suppl. 4: S303-S305
Saturno Hernández, P.J.; Gascón Cánovas, J.J. 1997: The validity of therapeutic utility and intrinsic value as indicators of drug prescription quality: an analysis of treatments in cases of the common cold Atencion Primaria 19(8): 400-406
Do, T.N.; Nguyen, T.M.T.; Do, M.H.; Masaya, K.; Dang, T.B.; Pham, T.L.; Yoshikawa, K.; Cao, T.T.T.; Nguyen, T.T.V.; Bui, D.D.; Nguyen, V.K.; Nguyen, T.L.; Fujita, M. 2012: Combining cohort analysis and monitoring of HIV early-warning indicators of drug resistance to assess antiretroviral therapy services in Vietnam Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(Suppl 4): S306-S312